Thermoregulation Among Individuals With First-episode Psychosis
NCT04369677 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2026-02-25
Summary
The project will evaluate thermoregulatory processes among individuals with and without first-episode psychosis.
Conditions
- Psychosis
- First Episode Psychosis
Sponsors & Collaborators
-
Nicholas Breitborde
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-17
- Primary Completion
- 2025-04-03
- Completion
- 2025-04-03
Countries
- United States
Study Locations
More Related Trials
-
Early Psychosis: Investigating Cognition
NCT07196423 ·Status: RECRUITING ·Phase: NA
-
Antipsychotic Effects of Oxytocin
NCT01621737 ·Status: TERMINATED ·Phase: NA
-
Enhancing the Prospective Prediction of Psychosis
NCT00291200 ·Status: COMPLETED
-
Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia
NCT02144155 ·Status: TERMINATED ·Phase: NA
-
Improving the Understanding of Catatonia in Autism
NCT02945423 ·Status: WITHDRAWN
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia
NCT01123317 ·Status: WITHDRAWN ·Phase: NA
-
E-Detection Tool for Emerging Mental Disorders
NCT05127278 ·Status: RECRUITING
-
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
NCT03651674 ·Status: UNKNOWN ·Phase: NA
-
The Topical Niacin Skin Flush Test in First Episode Psychosis
NCT01324297 ·Status: TERMINATED
-
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967 ·Status: NOT_YET_RECRUITING
-
Biomarkers in First Episode Schizophrenia
NCT02033382 ·Status: COMPLETED
-
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
NCT00247637 ·Status: COMPLETED
-
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535 ·Status: COMPLETED
-
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
NCT00789022 ·Status: UNKNOWN
-
Neuroplasticity in TBI and Schizophrenia
NCT03995368 ·Status: COMPLETED ·Phase: NA
-
Prospective Studies of the Pathogenesis of Schizophrenia
NCT00877552 ·Status: COMPLETED
-
Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics
NCT02366897 ·Status: COMPLETED ·Phase: NA
-
Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia
NCT03048370 ·Status: COMPLETED ·Phase: NA
-
Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies
NCT02670447 ·Status: RECRUITING
-
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671 ·Status: COMPLETED
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
NCT01269710 ·Status: COMPLETED
-
Early Medication Discontinuation and Long-term Clinical Outcome in FEP
NCT01926340 ·Status: COMPLETED